A publicly traded company on the London Stock Exchange, Roquefort Therapeutics develop pharmaceutical products in the pre-clinical phase. With some exciting drug developments on their books, they needed a sleek new website to deliver critical investor news and information.
It was a pleasure working with a team of experienced senior executives on developing this new web design, complete with a London Stock Exchange integration.
Together our teams create an optimised website, which included:
- Home
- About us
- Board & Senior management
- Our strategy
- Midkine
- What is Midkine
- Extensive research
- Drug development
- International collaborations
- Investors
- Regulatory news
- Share capital information
- Corporate governance
- Advisors
- Corporate documents
- Shareholder documents
- Financial reports
- Presentations
- Research reports
- Contact
Do you need a website integrated with your stock exchange listing? Contact our team.
